MA

Active Director Director DIN 09256787
DIN 09256787 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Mohd Atif

Data last updated:

Mohd Atif is a Director at Throone Healthcare Private Limited (since 2021). The company operates in Chemicals. Throone Healthcare Private Limited reported revenue of ₹5.7 Lakh (FY 2025).

DIN 09256787
Primary Designation Director
Industry Chemicals
First Appointment 27 Jul 2021
Oldest Company Age 5 yrs
Largest company Throone Healthcare Private Limited · ₹5.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Throone Healthcare Private Limited U24239UP2021PTC149606
Director27 Jul 20212021₹5.7 Lakh (FY 2025)Active

Board colleagues of Mohd Atif

NameDINCompanyDesignation
Mohd Shamsi09256786Throone Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Throone Healthcare Private Limited
Premium access

Shareholding and investment profile for Mohd Atif

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohd Atif

Mohd Atif currently holds 1 directorship: Throone Healthcare Private Limited (Director, since 27 Jul 2021, revenue ₹5.7 Lakh (FY 2025)).

Mohd Atif was first appointed on 27 Jul 2021 as Director at Throone Healthcare Private Limited.

The current boards of Mohd Atif's companies include Mohd Shamsi (Throone Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available